Pneumolysin induces release of matrix metalloproteinases-8 and -9 from human neutrophils Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Statins inhibit matrix metalloproteinase release from human lung fibroblasts Source: Eur Respir J 2010; 35: 637-646 Year: 2010
Biological role of matrix metalloproteinases: a critical balance Source: Eur Respir J 2011; 37: 191-208 Year: 2011
Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo Source: Eur Respir J 2002; 20: 170-176 Year: 2002
Exocytosis of matrix metalloproteinases (MMPs) by pulmonary and systemic polymorphonuclear neutrophils (PMN) in hospital acquired pneumonia (HAP) Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Compartmentalized neutrophil recruitment and matrix metalloprotease (MMP)-9 release after airway exposure to endotoxin in humans Source: Eur Respir J 2004; 24: Suppl. 48, 554s Year: 2004
Production of matrix metalloprotease-9 (MMP-9) by alveolar macrophages (AMs) from smokers: effect of corticosteroids and phosphodiesterase inhibition Source: Eur Respir J 2001; 18: Suppl. 33, 34s Year: 2001
Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17A in mouse airways Source: Annual Congress 2004 - Insights into asthma and COPD Year: 2004
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation Source: Eur Respir J 2009; 33: 134-141 Year: 2009
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space Source: Eur Respir J 2008; 32: 644-650 Year: 2008
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 92s Year: 2002
Matrix metalloproteinase 12 (MMP-12) expression in human monocyte-derived macrophages is enhanced by exposure to cigarette smoke and is resistant to suppression by dexamethasone Source: Eur Respir J 2004; 24: Suppl. 48, 107s Year: 2004
Matrix remodeling in IPF: the important role of MMPs-1, -2, -9 and TIMP-1, TIM-2 Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004
A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? Source: Eur Respir J 2011; 38: 1200-1214 Year: 2011
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002
Eosinophils contribute to extracellular matrix remodeling by enhancing pulmonary fibroblasts proliferation, differentiation and extracellular matrix proteins production in asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008